Comprehensive analysis of matrix metalloproteinases and their inhibitors in head and neck squamous cell carcinoma

References

• Johnson DE, Burtness B, Leemans CR, et al. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92.
   PubMed Web of Science ®Google Scholar
• Li Q, Li Y, Wang Y, et al. Oral administration of bifidobacterium breve promotes antitumor efficacy via dendritic cells-derived interleukin 12. Oncoimmunology. 2021;10(1):1868122.
   PubMed Web of Science ®Google Scholar
• Hashim D, Genden E, Posner M, et al. Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden. Ann Oncol. 2019;30(5):744–756.
   PubMed Web of Science ®Google Scholar
• Jou A, Hess J. Epidemiology and molecular biology of head and neck cancer. Oncol Res Treat. 2017;40(6):328–332.
   PubMed Web of Science ®Google Scholar
• Du E, Mazul AL, Farquhar D, et al. Long-term survival in head and neck cancer: impact of site, stage, smoking, and human papillomavirus status. Laryngoscope. 2019;129(11):2506–2513.
   PubMed Web of Science ®Google Scholar
• Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016;91(3):386–396.
   PubMed Web of Science ®Google Scholar
• Bates AM, Gomez Hernandez MP, Lanzel EA, et al. Matrix metalloproteinase (mmp) and immunosuppressive biomarker profiles of seven head and neck squamous cell carcinoma (hnscc) cell lines. Transl Cancer Res. 2018;7(3):533–542.
   PubMed Web of Science ®Google Scholar
• Iizuka S, Ishimaru N, Kudo Y. Matrix metalloproteinases: the gene expression signatures of head and neck cancer progression. Cancers (Basel). 2014;6(1):396–415.
   PubMed Web of Science ®Google Scholar
• Stanciu AE, Zamfir-Chiru-Anton A, Stanciu MM, et al. Serum level of matrix metalloproteinase-9 in patients with head and neck squamous cell carcinoma. Clin Lab. 2016;62(8):1569–1574.
   PubMed Web of Science ®Google Scholar
• Stanciu AE, Zamfir-Chiru-Anton A, Stanciu MM, et al. Imbalance between matrix metalloproteinases and tissue inhibitors of metalloproteinases promotes invasion and metastasis of head and neck squamous cell carcinoma. Clin Lab. 2017;63(10):1613–1620.
   PubMed Web of Science ®Google Scholar
• Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, et al. The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci. 2020;21(24):9739.
   PubMed Web of Science ®Google Scholar
• Laronha H, Caldeira J. Structure and function of human matrix metalloproteinases. Cells. 2020;9(5):1076.
   PubMed Web of Science ®Google Scholar
• Carey P, Low E, Harper E, et al. Metalloproteinases in ovarian cancer. Int J Mol Sci. 2021;22(7):3403.
   PubMed Web of Science ®Google Scholar
• Zou M, Du Y, Liu R, et al. Nanocarrier-delivered small interfering rna for chemoresistant ovarian cancer therapy. Wiley Interdiscip Rev RNA. 2021;12:e1648.
   PubMed Web of Science ®Google Scholar
• Geng X, Chen C, Huang Y, et al. The prognostic value and potential mechanism of matrix metalloproteinases among prostate cancer. Int J Med Sci. 2020;17(11):1550–1560.
   PubMed Web of Science ®Google Scholar
• Jiang H, Li H. Prognostic values of tumoral mmp2 and mmp9 overexpression in breast cancer: a systematic review and meta-analysis. BMC Cancer. 2021;21(1):149.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Avila G, Sommer B, Mendoza-Posada DA, et al. Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer. Crit Rev Oncol Hematol. 2019;137:57–83.
   PubMed Web of Science ®Google Scholar
• Olejarz W, Lacheta D, Kubiak-Tomaszewska G. Matrix metalloproteinases as biomarkers of atherosclerotic plaque instability. Int J Mol Sci. 2020;21(11):3946.
   Web of Science ®Google Scholar
• Riihila P, Nissinen L, Kahari VM. Matrix metalloproteinases in keratinocyte carcinomas. Exp Dermatol. 2021;30(1):50–61.
   PubMed Web of Science ®Google Scholar
• Murphy G. Tissue inhibitors of metalloproteinases. Genome Biol. 2011;12(11):233.
   PubMed Web of Science ®Google Scholar
• Bourboulia D, Stetler-Stevenson WG. Matrix metalloproteinases (mmps) and tissue inhibitors of metalloproteinases (timps): positive and negative regulators in tumor cell adhesion. Semin Cancer Biol. 2010;20(3):161–168.
   PubMed Web of Science ®Google Scholar
• Salimi Sartakhti J, Manshaei MH, Sadeghi M. Mmp-timp interactions in cancer invasion: an evolutionary game-theoretical framework. J Theor Biol. 2017;412:17–26.
   PubMed Web of Science ®Google Scholar
• Deng B, Ren JZ, Meng XQ, et al. Expression profiles of mmp-1 and timp-1 in lumbar intervertebral disc degeneration. Genet Mol Res. 2015;14(4):19080–19086.
   PubMed Web of Science ®Google Scholar
• Diboun I, Wernisch L, Orengo CA, et al. Microarray analysis after rna amplification can detect pronounced differences in gene expression using limma. BMC Genomics. 2006;7(1):252.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Nastou KC, et al. The string database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605–D612.
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cbioportal. Sci Signal. 2013;6(269):pl1.
   PubMed Web of Science ®Google Scholar
• Engebretsen S, Bohlin J. Statistical predictions with glmnet. Clin Epigenet. 2019;11(1):123.
   PubMed Web of Science ®Google Scholar
• Ye H, Yu T, Temam S, et al. Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics. 2008;9:69.
   PubMed Web of Science ®Google Scholar
• Hauff SJ, Raju SC, Orosco RK, et al. Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice. Otolaryngol Head Neck Surg. 2014;151(4):612–618.
   PubMed Web of Science ®Google Scholar
• Stokes A, Joutsa J, Ala-Aho R, et al. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma. Clin Cancer Res. 2010;16(7):2022–2035.
   PubMed Web of Science ®Google Scholar
• Pyeon D, Newton MA, Lambert PF, et al. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res. 2007;67(10):4605–4619.
   PubMed Web of Science ®Google Scholar
• Milner JM, Cawston TE. Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases. Curr Drug Targets Inflamm Allergy. 2005;4(3):363–375.
   PubMedGoogle Scholar
• Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002;295(5564):2387–2392.
   PubMed Web of Science ®Google Scholar
• Owyong M, Chou J, van den Bijgaart RJ, et al. Mmp9 modulates the metastatic Cascade and immune landscape for breast cancer anti-metastatic therapy. Life Sci Alliance. 2019;2(6):e201800226.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke RE, Libert C. Is there new hope for therapeutic matrix metalloproteinase inhibition?. Nat Rev Drug Discov. 2014;13(12):904–927.
   PubMed Web of Science ®Google Scholar
• Hu J, Van den Steen PE, Sang QX, et al. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat Rev Drug Discov. 2007;6(6):480–498.
   PubMed Web of Science ®Google Scholar
• Eiro N, Cid S, Aguado N, et al. Mmp1 and mmp11 expression in peripheral blood mononuclear cells upon their interaction with breast cancer cells and fibroblasts. Int J Mol Sci. 2020; 22(1):371.
   Web of Science ®Google Scholar
• Azevedo Martins JM, Rabelo-Santos SH, do Amaral Westin MC, et al. Tumoral and stromal expression of mmp-2, mmp-9, mmp-14, timp-1, timp-2, and vegf-a in cervical cancer patient survival: a competing risk analysis. BMC Cancer. 2020;20(1):660.
   PubMed Web of Science ®Google Scholar
• Scheau C, Badarau IA, Costache R, et al. The role of matrix metalloproteinases in the epithelial-mesenchymal transition of hepatocellular carcinoma. Anal Cell Pathol (Amst). 2019;2019:9423907.
   PubMedGoogle Scholar
• Olivares-Urbano MA, Grinan-Lison C, Zurita M, et al. Matrix metalloproteases and timps as prognostic biomarkers in breast cancer patients treated with radiotherapy: a pilot study. J Cell Mol Med. 2020;24(1):139–148.
   PubMed Web of Science ®Google Scholar
• Farina AR, Mackay AR. Gelatinase b/mmp-9 in tumour pathogenesis and progression. Cancers (Basel). 2014;6(1):240–296.
   PubMed Web of Science ®Google Scholar
• Wang S, Jia J, Liu D, et al. Matrix metalloproteinase expressions play important role in prediction of ovarian cancer outcome. Sci Rep. 2019;9(1):11677.
   PubMed Web of Science ®Google Scholar
• Amar S, Smith L, Fields GB. Matrix metalloproteinase collagenolysis in health and disease. Biochim Biophys Acta Mol Cell Res. 2017;1864(11 Pt A):1940–1951.
   PubMed Web of Science ®Google Scholar
• Khamis ZI, Iczkowski KA, Man YG, et al. Evidence for a proapoptotic role of matrix metalloproteinase-26 in human prostate cancer cells and tissues. J Cancer. 2016;7(1):80–87.
   PubMed Web of Science ®Google Scholar
• Kulic A, Dedic Plavetic N, Vrbanec J, et al. Low serum mmp-1 in breast cancer: a negative prognostic factor?. Biomarkers. 2012;17(5):416–421.
   PubMed Web of Science ®Google Scholar
• Overall CM, Kleifeld O. Tumour microenvironment – opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer. 2006;6(3):227–239.
   PubMed Web of Science ®Google Scholar
• Martin MD, Matrisian LM. The other side of mmps: protective roles in tumor progression. Cancer Metastasis Rev. 2007;26(3–4):717–724.
   PubMed Web of Science ®Google Scholar
• Chirco R, Liu XW, Jung KK, et al. Novel functions of timps in cell signaling. Cancer Metastasis Rev. 2006;25(1):99–113.
   PubMed Web of Science ®Google Scholar
• Fields GB. Mechanisms of action of novel drugs targeting angiogenesis-promoting matrix metalloproteinases. Front Immunol. 2019;10:1278.
   PubMed Web of Science ®Google Scholar
• Habel AF, Ghali RM, Bouaziz H, et al. Common matrix metalloproteinase-2 gene variants and altered susceptibility to breast cancer and associated features in Tunisian women. Tumour Biol. 2019;41(4):1010428319845749.
   Google Scholar
• Cathcart J, Pulkoski-Gross A, Cao J. Targeting matrix metalloproteinases in cancer: bringing new life to old ideas. Genes Dis. 2015;2(1):26–34.
   PubMed Web of Science ®Google Scholar
• Beeghly-Fadiel A, Lu W, Long JR, et al. Matrix metalloproteinase-2 polymorphisms and breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 2009;18(6):1770–1776.
   PubMed Web of Science ®Google Scholar
• Zucker S, Cao J, Chen WT. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene. 2000;19(56):6642–6650.
   PubMed Web of Science ®Google Scholar
• Offenberg H, Brunner N, Mansilla F, et al. Timp-1 expression in human colorectal cancer is associated with tgf-b1, loxl2, inhba1, tnf-aip6 and timp-2 transcript profiles. Mol Oncol. 2008;2(3):233–240.
   PubMed Web of Science ®Google Scholar
• Butler GS, Butler MJ, Atkinson SJ, et al. The timp2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase a. A kinetic study. J Biol Chem. 1998;273(2):871–880.
   PubMed Web of Science ®Google Scholar
• Nyberg P, Moilanen M, Paju A, et al. Mmp-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells. J Dent Res. 2002;81(12):831–835.
   PubMed Web of Science ®Google Scholar
• Nieminen MT, Listyarifah D, Hagstrom J, et al. Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive carcinogenesis through immunomodulation. Br J Cancer. 2018;118(3):428–434.
   PubMed Web of Science ®Google Scholar
• Parnanen P, Sorsa T, Tervahartiala T, et al. Isolation, characterization and regulation of moonlighting proteases from candida glabrata cell wall. Microb Pathog. 2020;149:104547.
   PubMed Web of Science ®Google Scholar
• Palosaari H, Pennington CJ, Larmas M, et al. Expression profile of matrix metalloproteinases (mmps) and tissue inhibitors of mmps in mature human odontoblasts and pulp tissue. Eur J Oral Sci. 2003;111(2):117–127.
   PubMed Web of Science ®Google Scholar